Background
Sodium bicarbonated Ringer’s solution (BRS) has been gradually applied to clinic in recent years, while few clinical studies focused on the efficacy of BRS among elderly patients undergoing major surgery until now. This randomized controlled trial investigated the lactate metabolism and clinical outcomes of sodium bicarbonate Ringer's solution vs. sodium lactated Ringer’s solution (LRS) in elderly patients undergoing gastrointestinal surgery.
Methods
Sixty-two elderly patients undergoing gastrointestinal surgery were enrolled in this prospective, randomized controlled study. The enrolled participants were assigned into the sodium bicarbonated Ringer’s solution group (BRS group) or lactated Ringer's solution group (LRS group) randomly, which received goal-directed fluid therapy with sodium bicarbonated Ringer’s solution or sodium lactated Ringer’s solution, respectively. The primary outcome was the lactate level at the end of the surgery. Secondary outcomes included pH, bicarbonate, BE, hemodynamics, plasma biochemistry, recovery of gastrointestinal function and postoperative complications within 30 days after surgery.
Results
Sixty patients completed the trial and were analyzed finally. At the end of surgery, the level of lactate was significantly lower in BRS group than that in the LRS group (1.00 vs. 1.89, p < 0.001), and the probability of hyperlactacemia was lower (3.3% vs. 40.0%, p = 0.002). PH, bicarbonate, BE, hemodynamics, plasma biochemical alterations and postoperative gastrointestinal function recovery were not significant different between the two groups (p > 0.05). However, compared to the LRS group, the BRS group had a lower risk of wound bleeding (10.0% vs. 36.7%, p = 0.033) and newly impaired liver function (16.7% vs. 50.0%, p = 0.006), lower red blood cells infusion (0 vs. 0, p = 0.021), lower albumin infusion (10 vs. 35, p = 0.040), and shorter length of postoperative hospital stay (9 vs. 11.5, p = 0.012).
Conclusions
Sodium bicarbonated Ringer’s solution is more effective for elderly patients undergoing gastrointestinal surgery compared with sodium lactated Ringer’s solution through reducing the lactate levels, reducing the risk of wound bleeding and impaired liver function, red blood cells and albumin infusion, and decreasing the length of hospital stay.
Trial registration: This randomized trial was approved by the Clinical Medical Research Ethics Committee of the First Affiliated Hospital of Anhui Medical University, China (PJ2020-15-21) and registered at the Chinese Clinical Trial Center (http://www.chictr.org.cn/index.aspx, identifier: ChiCTR2000039406,date: 26/10/2020).